{"schema_version":"1","generated_at":"2026-11-04T12:35:09.043Z","data_as_of":null,"url":"https://www.findmykol.com/kol/romnee-clark","json_url":"https://www.findmykol.com/kol/romnee-clark/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"romnee-clark","name":"Romnee Clark","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Tesaro","institution_url":"https://www.findmykol.com/institution/tesaro","city":"Indianapolis","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1699731117","openalex":"A5010564776"},"summary":"Romnee Clark is an Oncology physician affiliated with Tesaro. OpenAlex indexes 29 publications with 379 citations (h-index 12); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":29,"cited_by_count":379,"h_index":12,"latest_activity_year":2022,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02005315","title":"A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"OncoMed Pharmaceuticals, Inc.","source_url":"https://clinicaltrials.gov/study/NCT02005315","trial_url":"https://www.findmykol.com/trial/NCT02005315"},{"nct":"NCT00375310","title":"Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"Indiana University","source_url":"https://clinicaltrials.gov/study/NCT00375310","trial_url":"https://www.findmykol.com/trial/NCT00375310"}],"source":"trials"},"funding":{"award_count":1,"fiscal_years":{"first":2008,"last":2013},"rows_total":8,"shown":3,"withheld":5,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"P30CA082709","title":"Data and Safety Monitoring System","fiscal_year":2013,"amount_usd":"82641","organization":"INDIANA UNIVERSITY INDIANAPOLIS","source_url":"https://reporter.nih.gov/quickSearch/P30CA082709"},{"project":"P30CA082709","title":"Data and Safety Monitoring System","fiscal_year":2013,"amount_usd":"7137","organization":"INDIANA UNIVERSITY INDIANAPOLIS","source_url":"https://reporter.nih.gov/quickSearch/P30CA082709"},{"project":"P30CA082709","title":"Data and Safety Monitoring System","fiscal_year":2013,"amount_usd":"5357","organization":"INDIANA UNIVERSITY INDIANAPOLIS","source_url":"https://reporter.nih.gov/quickSearch/P30CA082709"}],"source":"grants"},"publications":{"total":29,"shown":5,"withheld":24,"matched_by":"OpenAlex author record","recent":[{"title":"International Association for the Study of Lung Cancer (IASLC) Study of the Impact of COVID-19 on International Lung Cancer Clinical Trials","year":2022,"journal":"Institutional Research Information System University of Turin (University of Turin)","status":"verified"},{"title":"PL02.09 International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials","year":2021,"journal":"Journal of Thoracic Oncology","source_url":"https://doi.org/10.1016/j.jtho.2021.08.033","status":"verified"},{"title":"QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.","year":2018,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.5514","status":"verified"},{"title":"A prospective evaluation of tolerability of niraparib dosing based upon baseline body weight (wt) and platelet (blplt) count: Blinded pooled interim safety data from the PRIMA Study","year":2018,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1093/annonc/mdy285.150","status":"verified"},{"title":"QUADRA: A phase II, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) in 4th or later line of therapy: Results from the tBRCAmut subset","year":2018,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1093/annonc/mdy285.152","status":"verified"}],"source":"works"},"contact":{"address_1":"535 BARNHILL DR","address_2":"RT 473","city":"Indianapolis","state":"IN","zip":"462025112","phone":"317-278-7576","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1699731117","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":5,"publications":24}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2010-02-08","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}